Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 2
2007 2
2009 3
2010 2
2011 5
2012 4
2013 2
2014 4
2015 2
2016 2
2017 7
2018 6
2019 9
2020 11
2021 7
2022 18
2023 12
2024 11
2025 9
2026 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Cannabidiol and neurodegeneration: From molecular mechanisms to clinical benefits.
Jha SK, Nelson VK, Suryadevara PR, Panda SP, Pullaiah CP, Nuli MV, Kamal M, Imran M, Ausali S, Abomughaid MM, Srivastava R, Deka R, Pritam P, Gupta N, Shyam H, Singh IK, Pandey BW, Dewanjee S, Jha NK, Jafari SM. Jha SK, et al. Ageing Res Rev. 2024 Sep;100:102386. doi: 10.1016/j.arr.2024.102386. Epub 2024 Jul 4. Ageing Res Rev. 2024. PMID: 38969143 Review.
Existing therapeutic options for NDs are only symptomatic relief and do not address root-causing factors, such as protein aggregation, oxidative stress, and neuroinflammation. Cannabidiol (CBD) is a non-psychotic natural cannabinoid obtained from Cannabis sativa that posse …
Existing therapeutic options for NDs are only symptomatic relief and do not address root-causing factors, such as protein aggregation, oxida …
Pharmacology of Medical Cannabis.
Amin MR, Ali DW. Amin MR, et al. Adv Exp Med Biol. 2019;1162:151-165. doi: 10.1007/978-3-030-21737-2_8. Adv Exp Med Biol. 2019. PMID: 31332738 Review.
The predominant psychotropic component is delta(9)-tetrahydrocannabinol (delta(9)-THC), while the major non-psychoactive ingredient is cannabidiol (CBD). These compounds have been shown to be partial agonists or antagonists at the prototypical cannabinoid receptors, CB1 an …
The predominant psychotropic component is delta(9)-tetrahydrocannabinol (delta(9)-THC), while the major non-psychoactive ingredient is ca …
Cannabidiol and Alzheimer's disease.
Marques BL, Campos AC. Marques BL, et al. Int Rev Neurobiol. 2024;177:121-134. doi: 10.1016/bs.irn.2024.04.014. Epub 2024 Jul 4. Int Rev Neurobiol. 2024. PMID: 39029982 Review.
However,recently anecdotal findings based on low-quality real-world data had prompted physicians, patients, and their relatives to consider the use of cannabinoids, especially Cannabidiol (CBD), for alleviating of AD symptoms. CBD the primary non-psychotomimetic compound f …
However,recently anecdotal findings based on low-quality real-world data had prompted physicians, patients, and their relatives to consider …
Cannabidiol and other non-psychotropic cannabinoids from Cannabis sativa as therapeutics for microglial-mediated neuroinflammation and neurodegeneration.
Fowler DK, Savage TM, Mackie DI. Fowler DK, et al. J Cannabis Res. 2026 May 13;8(1):82. doi: 10.1186/s42238-026-00445-5. J Cannabis Res. 2026. PMID: 42121212 Free PMC article. Review.
Non-psychotropic phytocannabinoids produced by Cannabis sativa, including cannabidiol, cannabigerol, cannabichromene and their varin and acidic analogs, are emerging as promising modulators of neuroinflammation, particularly through actions on microglia, the brain's reside …
Non-psychotropic phytocannabinoids produced by Cannabis sativa, including cannabidiol, cannabigerol, cannabichromene and their varin …
Neuroprotective effects of cannabidiol on dopaminergic neurodegeneration and alpha-synuclein accumulation in C. elegans models of Parkinson's disease.
Muhammad F, Liu Y, Wang N, Zhao L, Zhou Y, Yang H, Li H. Muhammad F, et al. Neurotoxicology. 2022 Dec;93:128-139. doi: 10.1016/j.neuro.2022.09.001. Epub 2022 Sep 13. Neurotoxicology. 2022. PMID: 36108815
Parkinson disease (PD) is the second most progressive neurodegenerative disorder of the central nervous system (CNS) in the elderly, causing motor impediments and cognitive dysfunctions. Dopaminergic (DA) neuron degeneration and alpha-synuclein (alpha-Syn) accumulation in …
Parkinson disease (PD) is the second most progressive neurodegenerative disorder of the central nervous system (CNS) in the elderly, causing …
Effects of chronic cannabidiol in a mouse model of naturally occurring neuroinflammation, neurodegeneration, and spontaneous seizures.
Dearborn JT, Nelvagal HR, Rensing NR, Takahashi K, Hughes SM, Wishart TM, Cooper JD, Wong M, Sands MS. Dearborn JT, et al. Sci Rep. 2022 Jul 4;12(1):11286. doi: 10.1038/s41598-022-15134-5. Sci Rep. 2022. PMID: 35789177 Free PMC article.
Cannabidiol (CBD) has gained attention as a therapeutic agent and is purported to have immunomodulatory, neuroprotective, and anti-seizure effects. ...It is possible that a higher dose of CBD could also reduce neurodegeneration and seizure frequency....
Cannabidiol (CBD) has gained attention as a therapeutic agent and is purported to have immunomodulatory, neuroprotective, and anti-se …
Assessing Cannabidiol as a Therapeutic Agent for Preventing and Alleviating Alzheimer's Disease Neurodegeneration.
Chen L, Sun Y, Li J, Liu S, Ding H, Wang G, Li X. Chen L, et al. Cells. 2023 Nov 21;12(23):2672. doi: 10.3390/cells12232672. Cells. 2023. PMID: 38067101 Free PMC article.
Neuroinflammation, which is central to AD's pathology, results in synaptic and neuronal damage, highlighting the importance of addressing inflammation and conserving neuronal integrity. Cannabidiol (CBD), derived from cannabis, is noted for its neuroprotective and anti-inf …
Neuroinflammation, which is central to AD's pathology, results in synaptic and neuronal damage, highlighting the importance of addressing in …
Cannabidiol for neurodegenerative disorders: A comprehensive review.
Bhunia S, Kolishetti N, Arias AY, Vashist A, Nair M. Bhunia S, et al. Front Pharmacol. 2022 Oct 25;13:989717. doi: 10.3389/fphar.2022.989717. eCollection 2022. Front Pharmacol. 2022. PMID: 36386183 Free PMC article. Review.
The profound effect of (9)-tetrahydrocannabinol (THC), the major psychoactive component of cannabis, has led to the discovery of the endocannabinoid system as a molecular target in the central nervous system (CNS). Cannabidiol (CBD), the major non-psychoactive component o …
The profound effect of (9)-tetrahydrocannabinol (THC), the major psychoactive component of cannabis, has led to the discovery of the endoca …
Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: Reversal by cannabidiol.
da Silva VK, de Freitas BS, Dornelles VC, Kist LW, Bogo MR, Silva MC, Streck EL, Hallak JE, Zuardi AW, Crippa JAS, Schröder N. da Silva VK, et al. Brain Res Bull. 2018 May;139:1-8. doi: 10.1016/j.brainresbull.2018.01.014. Epub 2018 Jan 31. Brain Res Bull. 2018. PMID: 29374603 Free article.
Evidence has demonstrated iron accumulation in specific brain regions of patients suffering from neurodegenerative disorders, and this metal has been recognized as a contributing factor for neurodegeneration. Using an experimental model of brain iron accumulation, we have …
Evidence has demonstrated iron accumulation in specific brain regions of patients suffering from neurodegenerative disorders, and this metal …
118 results